0001683168-22-003411.txt : 20220511 0001683168-22-003411.hdr.sgml : 20220511 20220511072118 ACCESSION NUMBER: 0001683168-22-003411 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 37 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220511 DATE AS OF CHANGE: 20220511 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Namliong SkyCosmos, Inc. CENTRAL INDEX KEY: 0001342219 STANDARD INDUSTRIAL CLASSIFICATION: INDUSTRIAL ORGANIC CHEMICALS [2860] IRS NUMBER: 203240178 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55909 FILM NUMBER: 22912064 BUSINESS ADDRESS: STREET 1: NO. 357, REN'AI STREET STREET 2: YONGKANG DISTRICT CITY: TAINAN CITY STATE: F5 ZIP: 71072 BUSINESS PHONE: 886-2542372 MAIL ADDRESS: STREET 1: NO. 357, REN'AI STREET STREET 2: YONGKANG DISTRICT CITY: TAINAN CITY STATE: F5 ZIP: 71072 FORMER COMPANY: FORMER CONFORMED NAME: Kreido Biofuels, Inc. DATE OF NAME CHANGE: 20061102 FORMER COMPANY: FORMER CONFORMED NAME: Gemwood Productions, Inc. DATE OF NAME CHANGE: 20051024 10-Q 1 namliong_i10q-033122.htm FORM 10-Q
0001342219 false 2022 Q1 --12-31 Yes Yes 0001342219 2022-01-01 2022-03-31 0001342219 2022-05-10 0001342219 2022-03-31 0001342219 2021-12-31 0001342219 2021-01-01 2021-03-31 0001342219 us-gaap:CommonStockMember 2020-12-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001342219 us-gaap:RetainedEarningsMember 2020-12-31 0001342219 2020-12-31 0001342219 us-gaap:CommonStockMember 2021-12-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001342219 us-gaap:RetainedEarningsMember 2021-12-31 0001342219 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001342219 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001342219 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001342219 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001342219 us-gaap:CommonStockMember 2021-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001342219 us-gaap:RetainedEarningsMember 2021-03-31 0001342219 2021-03-31 0001342219 us-gaap:CommonStockMember 2022-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001342219 us-gaap:RetainedEarningsMember 2022-03-31 0001342219 2021-01-01 2021-12-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

or

 

TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from            To           

 

Commission File Number 000-55909

 

NAMLIONG SKYCOSMOS, INC.

(Exact name of registrant as specified in its charter)

 

Nevada   20-3240178
(State or other jurisdiction of
incorporation or organization)
  (IRS Employer
Identification No.)

 

No. 357, Ren’ai Street
Yongkang District

Tainan City
, Taiwan
  71072
(Address of principal executive offices)   (Zip Code)

 

+886-2542372
(Registrant’s telephone number, including area code)
 
Kreido Biofuels, Inc.
(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES  NO

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES  NO

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) YES    NO

 

The number of shares outstanding of the registrant’s common stock, par value $0.0001 per share, as of May 10, 2022, was 14,706,513.

 

 

   

 

 

TABLE OF CONTENTS

 

    Page
PART I - FINANCIAL INFORMATION    
     
Item 1. Financial Statements   1
     
Condensed Balance Sheets as of March 31, 2022 and December 31, 2021   1
     
Condensed Statements of Operations (Unaudited) for the Three Months Ended March 31, 2022 and 2021   2
     
Condensed Statements of Cash Flows (Unaudited) for the Three Months Ended March 31, 2022 and 2021   3
     
Condensed Statements of Changes in Stockholders’ Deficit (Unaudited) for the Three Months Ended March 31, 2022 and 2021   4
     
Notes to Condensed Financial Statements (Unaudited)   5
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   10
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk   14
     
Item 4. Controls and Procedures   14
     
     
PART II - OTHER INFORMATION   15
     
Item 1. Legal Proceedings   15
     
Item 1A. Risk Factors   15
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   15
     
Item 3. Defaults Upon Senior Securities   15
     
Item 4. Mine Safety Disclosures   15
     
Item 5. Other Information   15
     
Item 6. Exhibits   16
     
SIGNATURES   17

 

 

 i 

 

 

CAUTIONARY NOTE CONCERNING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended that are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical facts, included in this Form 10-Q including, without limitation, statements in the “Market Overview” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s market projections, financial position, business strategy and the plans and objectives of management for future operations, events or developments which the Company expects or anticipates will or may occur in the future, including such things as future capital expenditures (including the amount and nature thereof); expansion and growth of the Company's business and operations; and other such matters are forward-looking statements. These statements are based on certain assumptions and analyses made by the Company in light of its experience and its perception of historical trends, current conditions and expected future developments, as well as other factors it believes are appropriate under the circumstances. However, whether actual results or developments will conform with the Company's expectations and predictions is subject to a number of risks and uncertainties, including general economic, market and business conditions; the business opportunities (or lack thereof) that may be presented to and pursued by the Company; changes in laws or regulation; and other factors, most of which are beyond the control of the Company.

 

These forward-looking statements can be identified by the use of predictive, future-tense or forward-looking terminology, such as “believes,” “anticipates,” “expects,” “estimates,” “plans,” “may,” “will,” or similar terms. These statements appear in a number of places in this filing and include statements regarding the intent, belief or current expectations of the Company, and its directors or its officers with respect to, among other things: (i) trends affecting the Company's financial condition or results of operations for its limited history; (ii) the Company's business and growth strategies; and (iii) the Company's financing plans. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve significant risks and uncertainties, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors. Such factors that could adversely affect actual results and performance include, but are not limited to, the Company's limited operating history, potential fluctuations in quarterly operating results and expenses, government regulation, technological change and competition.

 

Consequently, all of the forward-looking statements made in this Form 10-Q are qualified by these cautionary statements and there can be no assurance that the actual results or developments anticipated by the Company will be realized or, even if substantially realized, that they will have the expected consequence to or effects on the Company or its business or operations. The Company assumes no obligations to update any such forward-looking statements.

 

 

 ii 

 

 

PART I. FINANCIAL INFORMATION.

Item 1. Financial Statements

 

NAMLIONG SKYCOSMOS, INC.

(Formerly Kreido Biofuels, Inc.)

CONDENSED BALANCE SHEETS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

 

 

   March 31, 2022   December 31, 2021 
   (Unaudited)   (Audited) 
ASSETS          
Current asset:          
Cash  $   $ 
           
TOTAL ASSETS  $   $ 
           
LIABILITIES AND STOCKHOLDERS’ DEFICIT          
Current liabilities:          
Accounts payable and accrued liabilities  $7,000   $755 
Amount due to a related party   28,505     
           
Total current liabilities   35,505    755 
           
TOTAL LIABILITIES   35,505    755 
           
Commitments and contingencies        
           
STOCKHOLDERS’ DEFICIT          
Preferred stock, 10,000,000 shares authorized, $0.001 par value, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021        
Common stock, 300,000,000 shares authorized, $0.001 par value, 14,706,513 and 14,706,513 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively   14,706    14,706 
Additional paid-in capital   49,435,627    49,435,627 
Accumulated deficit   (49,485,838)   (49,451,088)
           
Stockholders’ deficit   (35,505)   (755)
           
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT  $   $ 

 

See accompanying notes to condensed financial statements.

 

 

 1 

 

 

NAMLIONG SKYCOSMOS, INC.

(Formerly Kreido Biofuels, Inc.)

CONDENSED STATEMENTS OF OPERATIONS

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

         
   Three months ended
March 31,
 
   2022   2021 
         
Revenue, net  $   $ 
           
Operating expenses:          
General and administrative expenses   34,750    2,300 
Total operating expenses   34,750    2,300 
           
LOSS FROM OPERATION   (34,750)   (2,300)
           
Income tax expense        
           
NET LOSS  $(34,750)  $(2,300)
           
Net loss per share – Basic and Diluted          
Basic  $(0.00)  $(0.00)
Diluted  $(0.00)  $(0.00)
           
Weighted average common shares outstanding          
Basic   14,706,513    1,956,452 
Diluted   14,706,513    1,956,452 

 

 

See accompanying notes to condensed financial statements.

 

 2 

 

 

 

NAMLIONG SKYCOSMOS, INC.

(Formerly Kreido Biofuels, Inc.)

CONDENSED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

 

                          
   Three Months Ended March 31, 2022 and 2021 
   Common stock  

Additional

paid-in

   Accumulated   Total stockholders’ 
   No. of shares   Amount   capital   deficit   deficit 
Balance as of January 1, 2021   1,956,452   $1,956   $48,984,877   $(49,057,571)  $(69,438)
Net loss for the period               (2,300)   (2,300)
Balance as of March 31, 2021   1,956,452   $1,956   $48,984,877   $(49,059,871)  $(71,738)
                          
                          
                          
Balance as of January 1, 2022   14,706,513   $14,706   $49,435,627   $(49,451,088)  $(755)
Net loss for the period               (34,750)   (34,750)
Balance as of March 31, 2022   14,706,513   $14,706   $49,435,627   $(49,485,838)  $(35,505)

 

 

See accompanying notes to condensed financial statements.

 

 3 

 

 

 

NAMLIONG SKYCOSMOS, INC.

(Formerly Kreido Biofuels, Inc.)

CONDENSED STATEMENTS OF CASH FLOWS

(Currency expressed in United States Dollars (“US$”))

(Unaudited)

 

 

         
   Three months ended March 31, 
   2022   2021 
         
Cash flows from operating activities:          
Net loss  $(34,750)  $(2,300)
           
Change in operating assets and liabilities:          
Accounts payable and accrued liabilities   6,245    975 
Accounts payable, related party       1,325 
Net cash used in operating activities   (28,505)    
           
Cash flows from financing activities:          
Advance from a related party   28,505     
Net cash provided by financing activities   28,505     
           
Net change in cash and cash equivalents        
           
BEGINNING OF PERIOD        
           
END OF PERIOD  $   $ 
           
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:          
Cash paid for income taxes  $   $ 
Cash paid for interest  $   $ 

 

 

See accompanying notes to condensed financial statements.

 

 4 

 

 

NAMLIONG SKYCOSMOS, INC.

(Formerly Kreido Biofuels, Inc.)

NOTES TO COMBINED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2022 AND 2021

(Currency expressed in United States Dollars (“US$”), except for number of shares)

(Unaudited)

 

 

NOTE – 1 DESCRIPTION OF BUSINESS AND ORGANIZATION

 

Namliong Skycosmos, Inc. (formerly Kreido Biofuels, Inc.) (the “Company” or “KRBF”) was incorporated as Gemwood Productions, Inc. under the laws of the State of Nevada on February 7, 2005. Gemwood Productions, Inc. changed its name to Kreido Biofuels, Inc. on November 2, 2006. On April 19, 2022, we changed the company name to Namliong Skycosmos, Inc.

 

Our current business will be to seek to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.

 

Our acquisition strategy will be to assess a broad range of potential business combination targets and complete a business combination.   In doing so, we will evaluate the historical financial statements of the target, its management, and projected future results. In evaluating a prospective target business, we expect to conduct a thorough due diligence review that will encompass, among other things, meetings with incumbent management and employees, document reviews, inspection of facilities, as well as a review of financial and other information that will be made available to us.

 

We are not prohibited from pursuing a business combination with a company that is affiliated with our management, but we have no plans to do so. We do not plan to retain a significant equity position after closing of any acquisition and management does not plan to continue as part of the new management team.

 

We have not selected any specific business combination target. Our sole officer and director presently has, and in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity. Accordingly, if our officer and director becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We do not believe, however, that the fiduciary duties or contractual obligations of our officer/director will materially affect our ability to complete our business combination.

 

Our executive officer is not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combination targets and monitoring the related due diligence.

 

On December 14, 2021, certain shareholders owning 13,099,243 of our common stock, representing a majority of issued and outstanding shares, agreed to sell their shares to 6 shareholders. This constitutes a change in control of the Company.

 

 

 

 

 5 

 

 

NOTE – 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying condensed financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying financial statements and notes.

 

lBasis of presentation

 

These accompanying condensed financial statements have been prepared in U.S. Dollars in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the interim period ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis, and the financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 18, 2022.

 

lUse of estimates and assumptions

 

In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

lNet loss per share

 

Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.

 

lIncome taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

lUncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.

 

 

 

 

 6 

 

 

 

lRelated parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

lCommitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

lRecent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

 

 

 

 7 

 

 

In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.

 

On January 1, 2020, the Company adopted ASU No. 2017-04, “Intangibles and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

NOTE – 3 GOING CONCERN UNCERTAINTIES

 

The accompanying condensed financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However, Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans, which raises substantial doubt about the ability of the Company to continue as a going concern.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

NOTE – 4 AMOUNT DUE TO A RELATED PARTY

 

The amount represented temporary advances from the Company’s director for working capital purpose, which were unsecured, interest-free and had no fixed terms of repayments.

 

NOTE – 5 STOCKHOLDERS’ DEFICIT

 

Preferred stock

 

The Company’s authorized shares were 300,000,000 shares of preferred stock, with a par value of $0.001.

 

Common Stock

 

The Company’s Articles of Incorporation authorize the issuance of up to 300,000,000 shares of its common stock, par value $0.001 per share, and 10,000,000 preferred shares, also $0.001 par value.

 

There were 14,706,513 and 14,706,513 shares of common stock outstanding at March 31, 2022 and December 31, 2021, respectively.

 

There were no preferred shares issued and outstanding during any periods presented.

 

 

 

 

 8 

 

 

NOTE – 6 INCOME TAX

 

On December 22, 2017, the 2019 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. The Company does not have any foreign earnings and therefore, we do not anticipate the impact of a transition tax.

 

The cumulative tax effect at the expected rate of 21% as of March 31, 2022 and December 31, 2021 of significant items comprising our net deferred tax amount is as follows:

 

   March 31, 2022   December 31, 2021 
         
Net operating loss carryover  $49,485,838   $49,451,088 
Deferred tax asset   10,392,026    10,384,728 
Impact of rate changes          
Less: valuation allowance   (10,392,026)   (10,384,728)
Net deferred tax asset  $   $ 

 

At March 31, 2022, the Company had net operating loss carry forwards of approximately $49,485,838 that may be offset against future taxable income. The Tax Act also changed the rules on net operating loss carry forwards. The 20-year limitation was eliminated, giving the taxpayer the ability to carry forward losses indefinitely. However, NOL carry forward arising after January 1, 2020, will now be limited to 80 percent of taxable income.

 

No tax benefit has been reported in the period ended March 31, 2022, the Company’s financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for federal income tax reporting purposes are subject to annual limitations. A change in ownership may limit net operating loss carry forwards in future years. The benefits of our deferred tax assets, including our NOLs, built-in losses and tax credits would be reduced or potentially eliminated if we experienced an “ownership change” under Section 382.

 

Based on our analysis performed as of March 31, 2022, the Company has experienced an ownership change as defined by Section 382, and, therefore, the NOLs, built-in losses and tax credits we have generated should be subject to a Section 382 limitation as of this reporting date.

 

NOTE – 7 RELATED PARTY TRANSACTIONS

 

During the three months ended March 31, 2022 and 2021, the Company has been provided with free office space by its shareholders. The management determined that such cost is nominal and did not recognize the rent expense in its financial statements.

 

Apart from the transactions and balances detailed elsewhere in these accompanying financial statements, the Company has no other significant or material related party transactions during the periods presented.

 

NOTE – 8 COMMITMENTS AND CONTINGENCIES

 

As of March 31, 2022, the Company has no material commitments or contingencies.

 

NOTE – 9 SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before condensed financial statements are issued, the Company has evaluated all events or transactions that occurred after March 31, 2022, up through the date the Company issued the unaudited condensed financial statements.

 

 

 

 

 

 9 

 

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Namliong SkyCosmos, Inc. (“we” or the “Company”) was incorporated on February 7, 2005 under the name Gemwood Productions. On November 2, 2006, we changed our name to Kreido Biofuels, Inc. On April 19, 2022, the Company changed its name to Namliong SkyCosmos, Inc.

 

Our registration statement on Form SB-2, file number 333-140718, became effective on June 28, 2007.  Subsequent to the filing of our Annual Report on Form 10-K for the year ended December 31, 2008, we continued to file annual and quarterly reports with the Securities and Exchange Commission on a voluntary basis through the quarter ended September 30, 2009.  On February 16, 2009, we elected to terminate our registration and our election to file periodic reports. On March 2, 2018, we filed a registration statement on Form 10, and the registration statement became effective on May 8, 2018.

 

On November 10, 207, the Company issued 142,924,167 shares of common stock to Reed Petersen, its then officer and director in consideration of cash of $21,434 paid by him to satisfy accounts payable of the Company, and in conversion of $150,075 in accounts payable which he had acquired from the owners of that debt. This transaction was exempt under section 4(2) of the Securities Act of 1933 as one not involving any public solicitation or public offering, and was also exempt under Section 4(5) as an offering solely to accredited investors not involving any public solicitation or public offering.

  

On June 5, 2018, the Company and its sole officer and director, G. Reed Petersen, entered into that certain Stock Purchase Agreement (the “Stock Purchase Agreement”), pursuant to which Mr. Petersen agreed to sell to certain purchasers an aggregate of 142,924,167 shares of common stock of the Company (the “Control Shares”), representing approximately 73% of the issued and outstanding stock of the Company, for aggregate cash consideration of $420,000 in accordance with the terms and conditions of the Stock Purchase Agreement. The sale of the Control Shares consummated on June 29, 2018. In connection with the sale of the Control Shares, G. Reed Petersen resigned from his positions as the sole executive officer and director of the Company, effective June 29, 2018.  Mr. Petersen’s departure was not due to any dispute or disagreement with the Company on any matter related to the Company’s operations, policies or practices.  Concurrently, the Board of Directors appointed Wai Lim Wong to fill the vacancies created by Mr. Petersen’s resignation, and to serve as the Company’s sole Director, Chief Executive Officer, Chief Financial Officer and Secretary.

 

On September 7, 2021, Board of Directors Board of Directors accepted the resignation of Wai Lim Wong, and appointed CHAN Kwok Wai Davy as a new member of the Board of Directors and CEO.

 

On December 14, 2021, the Company, nine stockholders (the “Selling Stockholders”) and six purchasers (the “Purchasers”) entered into a Stock Purchase Agreement (the “SPA”), pursuant to which the Purchasers agreed to purchase from the Selling Stockholders 13,099,243 shares of common stock of the Company, par value $0.001 (collectively, the “Shares”), constituting approximately 89% of the issued and outstanding shares of common stock of the Company, for aggregate consideration of Four Hundred Twenty Thousand Dollars ($420,000) in accordance with the terms and conditions of the SPA. The acquisition of the Shares consummated on December 20, 2021, and the Shares were ultimately purchased by the following individuals:

 

Selling Shareholder No. of Common Stock Purchaser
DOU Chu Ju 554,856 PG MAX & CO, LLC
ZHANG Chao 214,387 CHEN,HSUEH-NI
HEUNG Kin Leung Kenny 55,000 HSIAO, CHUNG-PIN
HEUNG Pak Kuen 55,000 HSIAO, CHUNG-PIN
HEUNG Teui Yee 55,000 HSIAO, YU-CHIAO
KWAN Chin Man 55,000 HSIAO, YU-CHIAO
LEUNG Wong Hung 55,000 HSU, CHENG-HSING
MAK Chit Ming Brian 55,000 HSU, CHENG-HSING
Pang King Sau Nelson 12,000,000 Orient Express & Co., Ltd.
     
Total 13,099,243  

 

 

 10 

 

 

Orient Express & Co., Ltd. holds a controlling interest in the Company, and may unilaterally determine the election of the Board and other substantive matters requiring approval of the Company’s stockholders. Cheng Hsing Hsu, our new Chief Financial Officer and Director, is the director and controlling shareholder of Orient Express & Co., Ltd.

 

Upon the consummation of the sale, Chan Kwok Wai Davy, our sole executive officer and director, resigned from all of his positions with the Company, effective December 20, 2021. His resignation was not due to any dispute or disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

 

Concurrently with such resignation, the following individuals were appointed to serve in the positions set forth next to their names, until the next annual meeting of stockholders of the Company and until such director’s successor is elected and qualified or until such director’s earlier death, resignation or removal:

 

Name Position
HSIAO, Chung Pin Chief Executive Officer and Director
HSIAO, Yu-Chiao Secretary and Director
HSU, Cheng Hsing Chief Financial Officer and Director

 

Chung Pin HSIAO and Yu Chiao HSIAO are siblings. Except as set forth in the foregoing, none of the directors or executive officers has a direct family relationship with any of the Company’s directors or executive officers, or any person nominated or chosen by the Company to become a director or executive officer. All officers and directors will serve in his or her positions without compensation. The Company hopes to enter into a compensatory arrangement with each officer in the future.

 

Our current business is to seek to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. Our acquisition strategy is to assess a broad range of potential business combination targets and complete a business combination. In doing so, we will evaluate the historical financial statements of the target, its management, and projected future results. In evaluating a prospective target business, we expect to conduct a thorough due diligence review that will encompass, among other things, meetings with incumbent management and employees, document reviews, inspection of facilities, as well as a review of financial and other information that will be made available to us.

 

Results of Operations

 

Following is management’s discussion of the relevant items affecting results of operations for the three months ended March 31, 2022 and 2021.

 

Revenues, net. The Company has not generated revenues during the three months ended March 31, 2022 and 2021.

 

General and Administrative Expenses. For the three months ended March 31, 2022, the Company had general and administrative expenses of $34,750, as compared to $2,300 for the same period ended March 31, 2021. The increase was mainly due to the addition of legal fee, accounting and audit fee incurred by the Company.

Net Loss. For the three months ended March 31, 2022, the Company incurred a net loss of $34,750, as compared to a net loss of $2,300 for the same period ended March 31, 2021.    The increase in net loss was due to the increase in professional fees and general and administrative fees incurred by the Company.

 

Liquidity and Capital Resources

 

As of March 31, 2022, our primary source of liquidity consisted of $-0- in cash and cash equivalents. We hold most of our cash reserves in local checking accounts with local financial institutions. Since inception, we have financed our operations through a combination of short and long-term loans, and through the private placement of our common stock.

 

 

 11 

 

 

We have sustained significant net losses which have resulted in a total stockholders’ deficit as of March 31, 2022 of $35,505 and are currently experiencing a substantial shortfall in operating capital which raises doubt about our ability to continue as a going concern. We anticipate a net loss for the three months ended March 31, 2022 and with the expected cash requirements for the coming months, without additional cash inflows from an increase in revenues combined with continued cost-cutting or a receipt of cash from capital investment, there is substantial doubt as to the Company’s ability to continue operations.

 

There is presently no agreement in place with any source of financing for the Company and we cannot assure you that the Company will be able to raise any additional funds, or that such funds will be available on acceptable terms.  Funds raised through future equity financing will likely be substantially dilutive to current shareholders.  Lack of additional funds will materially affect the Company and its business and may cause us to cease operations.  Consequently, shareholders could incur a loss of their entire investment in the Company.

 

Off-Balance Sheet Arrangements

 

We do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to investors.  

 

Contractual Obligations

 

As a “smaller reporting company” as defined by Item 10 of Regulation S-K, the Company is not required to provide this information.

 

Critical accounting policies

 

lUse of estimates and assumptions

 

In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

lNet loss per share

 

Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.

 

lIncome taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

 

 12 

 

 

lUncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.

 

lRelated parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

lCommitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

 

 13 

 

 

lRecent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

 

In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.

 

On January 1, 2020, the Company adopted ASU No. 2017-04, “Intangibles and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

  

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a “smaller reporting company”, we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures.

 

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed under the Securities Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to our management, to allow for timely decisions regarding required disclosure.

 

As of March 31, 2022, the end of our fiscal quarter, we carried out an evaluation, under the supervision of our Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of our disclosure controls and procedures. Based on the foregoing, we concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report.   We do not have a formal audit committee.

 

Changes in Internal Controls

 

There have been no changes in our internal controls over financial reporting identified in connection with the evaluation required by paragraph (d) of Securities Exchange Act Rule 13a-15 or Rule 15d-15 that occurred in the quarter ended March 31, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

  

 

 

 

 14 

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time, we may become involved in litigation relating to claims arising out of its operations in the normal course of business. We are not involved in any pending legal proceeding or litigation and, to the best of our knowledge, no governmental authority is contemplating any proceeding to which we area party or to which any of our properties is subject, which would reasonably be likely to have a material adverse effect on us.

 

Item 1A. Risk Factors

 

As a “smaller reporting company”, we are not required to provide the information required by this Item.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None.

 

 

 

 

 15 

 

 

Item 6. Exhibits

  

Exhibit No.   Description
     
3.1   Articles of Incorporation (1)
3.2   Certificate of Amendment*
3.3   Amended and Restated Bylaws (2)
4.1   Form of Common Stock Certificate (1)
4.2   Description of Securities (1)
31.1   Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Executive Officer*
31.2   Rule 13(a)-14(a)/15(d)-14(a) Certification of Principal Financial Officer*
32.1   Rule 1350 Certification of Principal Executive Officer*
32.2   Rule 1350 Certification of Principal Financial Officer*
     
101.INS   Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document) (3)
101.SCH   Inline XBRL Taxonomy Extension Schema Document (3)
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document (3)
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document (3)
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document (3)
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document (3)
104   Cover Page Interactive Data File (embedded within the Inline XBRL document) (3)

_________________ 

  * Filed herewith.
  (1) Incorporated by reference to the Exhibits to the Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 18, 2022.
  (2) Incorporated by reference to Exhibit 3.3 to the Annual Report on Form 10-KSB filed with the Securities and Exchange Commission on April 4, 2007 (File No. 333-130606).
  (3) XBRL Information is furnished and not filed or a part of a registration statement or prospectus for purposes of Section 11 or 12 of the Securities Act is deemed not filed for purposes of Section 18 of the Exchange Act and otherwise is not subject to liability under these sections.

 

 

 

 16 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

  

May 11, 2022 NAMLIONG SKYCOSMOS, INC.
   
   
  By: /s/ Chung Pin HSIAO
    Chung Pin HSIAO
    Chief Executive Officer and Director
     

 

 

 

 17 

 

EX-31.1 2 namliong_ex3101.htm CERTIFICATION

Exhibit 31.1

 

Certification of Principal Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Chung Pin HSIAO, certify that:

 

1.I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2022, of NAMLIONG SKYCOSMOS, INC.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; 

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

 

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; 

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

 

Date:  May 11, 2022

  By: /s/ Chung Pin HSIAO  
  Chung Pin HSIAO  
  Principal Executive Officer  
EX-31.2 3 namliong_ex3102.htm CERTIFICATION

Exhibit 31.2

 

Certification of Principal Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

 

I, Cheng Hsing HSU, certify that:

 

1. I have reviewed this quarterly report on Form 10-Q for the quarter ended March 31, 2022, of NAMLIONG SKYCOSMOS, INC.; 

 

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 

4. The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: 

 

a. Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared; 

 

b. Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; 

 

c. Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 

d. Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; 

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions): 

 

a. All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and 

 

b. Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting. 

 

Date:  May 11, 2022

  By: /s/ Cheng Hsing HSU  
  Cheng Hsing HSU  
  Principal Financial Officer  
EX-32.1 4 namliong_ex3201.htm CERTIFICATION

Exhibit 32.1

 

 

 

Certification of Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Chung Pin HSIAO, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the quarterly report on Form 10-Q for the quarter ended March 31, 2022, of NAMLIONG SKYCOSMOS, INC. fully complies with the requirements of Section 13(a) or 15(d) of  the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of NAMLIONG SKYCOSMOS, INC.

 

Date: May 11, 2022

 

By: /s/ Chung Pin HSIAO  
Chung Pin HSIAO  
Chief Executive Officer  
EX-32.2 5 namliong_ex3202.htm CERTIFICATION

Exhibit 32.2

 

 

Certification of Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

 

I, Cheng Hsing HSU, certify pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the quarterly report on Form 10-Q for the quarter ended March 31, 2022, of NAMLIONG SKYCOSMOS, INC. fully complies with the requirements of Section 13(a) or 15(d) of  the Securities Exchange Act of 1934 and that information contained in such Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of NAMLIONG SKYCOSMOS, INC.

 

Date: May 11, 2022

 

By: /s/ Cheng Hsing HSU  
Cheng Hsing HSU  
Chief Financial Officer  
EX-101.SCH 6 krbf-20220331.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - GOING CONCERN UNCERTAINTIES link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - AMOUNT DUE TO A RELATED PARTY link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - STOCKHOLDERS’ DEFICIT link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - INCOME TAX link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - INCOME TAX (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - STOCKHOLDERS’ DEFICIT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - INCOME TAX - Schedule of Deferred Taxes (Details) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - INCOME TAX (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 krbf-20220331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 krbf-20220331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 krbf-20220331_lab.xml XBRL LABEL FILE Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Entity Information, Former Legal or Registered Name Statement of Financial Position [Abstract] ASSETS Current asset: Cash TOTAL ASSETS LIABILITIES AND STOCKHOLDERS’ DEFICIT Current liabilities: Accounts payable and accrued liabilities Amount due to a related party Total current liabilities TOTAL LIABILITIES Commitments and contingencies STOCKHOLDERS’ DEFICIT Preferred stock, 10,000,000 shares authorized, $0.001 par value, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021 Common stock, 300,000,000 shares authorized, $0.001 par value, 14,706,513 and 14,706,513 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively Additional paid-in capital Accumulated deficit Stockholders’ deficit TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT Preferred Stock, Shares Authorized Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Shares Authorized Common Stock, Par or Stated Value Per Share Common Stock, Shares, Issued Common Stock, Shares, Outstanding Income Statement [Abstract] Revenue, net Operating expenses: General and administrative expenses Total operating expenses LOSS FROM OPERATION Income tax expense NET LOSS Net loss per share – Basic and Diluted Basic Diluted Weighted average common shares outstanding Basic Diluted Statement [Table] Statement [Line Items] Beginning balance, value Shares, Outstanding, Beginning Balance Net loss for the period Ending balance, value Shares, Outstanding, Ending Balance Statement of Cash Flows [Abstract] Cash flows from operating activities: Net loss Change in operating assets and liabilities: Accounts payable and accrued liabilities Accounts payable, related party Net cash used in operating activities Cash flows from financing activities: Advance from a related party Net cash provided by financing activities Net change in cash and cash equivalents BEGINNING OF PERIOD END OF PERIOD SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: Cash paid for income taxes Cash paid for interest Organization, Consolidation and Presentation of Financial Statements [Abstract] DESCRIPTION OF BUSINESS AND ORGANIZATION Accounting Policies [Abstract] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES GOING CONCERN UNCERTAINTIES Amount Due To Related Party AMOUNT DUE TO A RELATED PARTY Equity [Abstract] STOCKHOLDERS’ DEFICIT Income Tax Disclosure [Abstract] INCOME TAX Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Subsequent Events [Abstract] SUBSEQUENT EVENTS Basis of presentation Use of estimates and assumptions Net loss per share Income taxes Uncertain tax positions Related parties Commitments and contingencies Recent accounting pronouncements INCOME TAX - Schedule of Deferred Taxes Net operating loss carryover Deferred tax asset Impact of rate changes Less: valuation allowance Net deferred tax asset Effective Income Tax Rate Reconciliation, Percent Operating Loss Carryforwards Assets Liabilities, Current Liabilities Operating Expenses Weighted Average Number of Shares Outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Shares, Outstanding Increase (Decrease) in Accounts Payable and Accrued Liabilities Net Cash Provided by (Used in) Operating Activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Stockholders' Equity Note Disclosure [Text Block] Commitments and Contingencies, Policy [Policy Text Block] Deferred Tax Assets, Valuation Allowance EX-101.PRE 10 krbf-20220331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover - shares
3 Months Ended
Mar. 31, 2022
May 10, 2022
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 31, 2022  
Document Fiscal Period Focus Q1  
Document Fiscal Year Focus 2022  
Current Fiscal Year End Date --12-31  
Entity File Number 000-55909  
Entity Registrant Name NAMLIONG SKYCOSMOS, INC.  
Entity Central Index Key 0001342219  
Entity Tax Identification Number 20-3240178  
Entity Incorporation, State or Country Code NV  
Entity Address, Address Line One No. 357  
Entity Address, Address Line Two Ren’ai Street  
Entity Address, Address Line Three Yongkang District  
Entity Address, City or Town Tainan City  
Entity Address, Country TW  
Entity Address, Postal Zip Code 71072  
City Area Code 886  
Local Phone Number 2542372  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company true  
Entity Common Stock, Shares Outstanding   14,706,513
Entity Information, Former Legal or Registered Name Kreido Biofuels, Inc.  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Current asset:    
Cash $ 0 $ 0
TOTAL ASSETS
Current liabilities:    
Accounts payable and accrued liabilities 7,000 755
Amount due to a related party 28,505 0
Total current liabilities 35,505 755
TOTAL LIABILITIES 35,505 755
Commitments and contingencies
STOCKHOLDERS’ DEFICIT    
Preferred stock, 10,000,000 shares authorized, $0.001 par value, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021 0 0
Common stock, 300,000,000 shares authorized, $0.001 par value, 14,706,513 and 14,706,513 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively 14,706 14,706
Additional paid-in capital 49,435,627 49,435,627
Accumulated deficit (49,485,838) (49,451,088)
Stockholders’ deficit (35,505) (755)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $ 0 $ 0
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Balance Sheets (Unaudited) (Parenthetical) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Statement of Financial Position [Abstract]    
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
Common Stock, Shares Authorized 300,000,000 300,000,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares, Issued 14,706,513 14,706,513
Common Stock, Shares, Outstanding 14,706,513 14,706,513
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]    
Revenue, net $ 0 $ 0
Operating expenses:    
General and administrative expenses 34,750 2,300
Total operating expenses 34,750 2,300
LOSS FROM OPERATION (34,750) (2,300)
Income tax expense 0 0
NET LOSS $ (34,750) $ (2,300)
Net loss per share – Basic and Diluted    
Basic $ (0.00) $ (0.00)
Diluted $ (0.00) $ (0.00)
Weighted average common shares outstanding    
Basic 14,706,513 1,956,452
Diluted 14,706,513 1,956,452
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Changes in Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 1,956 $ 48,984,877 $ (49,057,571) $ (69,438)
Shares, Outstanding, Beginning Balance at Dec. 31, 2020 1,956,452      
Net loss for the period (2,300) (2,300)
Ending balance, value at Mar. 31, 2021 $ 1,956 48,984,877 (49,059,871) (71,738)
Shares, Outstanding, Ending Balance at Mar. 31, 2021 1,956,452      
Beginning balance, value at Dec. 31, 2021 $ 14,706 49,435,627 (49,451,088) (755)
Shares, Outstanding, Beginning Balance at Dec. 31, 2021 14,706,513      
Net loss for the period (34,750) (34,750)
Ending balance, value at Mar. 31, 2022 $ 14,706 $ 49,435,627 $ (49,485,838) $ (35,505)
Shares, Outstanding, Ending Balance at Mar. 31, 2022 14,706,513      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities:    
Net loss $ (34,750) $ (2,300)
Change in operating assets and liabilities:    
Accounts payable and accrued liabilities 6,245 975
Accounts payable, related party 0 1,325
Net cash used in operating activities (28,505) 0
Cash flows from financing activities:    
Advance from a related party 28,505 0
Net cash provided by financing activities 28,505 0
Net change in cash and cash equivalents
BEGINNING OF PERIOD 0 0
END OF PERIOD 0 0
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:    
Cash paid for income taxes 0 0
Cash paid for interest $ 0 $ 0
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.1
DESCRIPTION OF BUSINESS AND ORGANIZATION
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
DESCRIPTION OF BUSINESS AND ORGANIZATION

NOTE – 1 DESCRIPTION OF BUSINESS AND ORGANIZATION

 

Namliong Skycosmos, Inc. (formerly Kreido Biofuels, Inc.) (the “Company” or “KRBF”) was incorporated as Gemwood Productions, Inc. under the laws of the State of Nevada on February 7, 2005. Gemwood Productions, Inc. changed its name to Kreido Biofuels, Inc. on November 2, 2006. On April 19, 2022, we changed the company name to Namliong Skycosmos, Inc.

 

Our current business will be to seek to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.

 

Our acquisition strategy will be to assess a broad range of potential business combination targets and complete a business combination.   In doing so, we will evaluate the historical financial statements of the target, its management, and projected future results. In evaluating a prospective target business, we expect to conduct a thorough due diligence review that will encompass, among other things, meetings with incumbent management and employees, document reviews, inspection of facilities, as well as a review of financial and other information that will be made available to us.

 

We are not prohibited from pursuing a business combination with a company that is affiliated with our management, but we have no plans to do so. We do not plan to retain a significant equity position after closing of any acquisition and management does not plan to continue as part of the new management team.

 

We have not selected any specific business combination target. Our sole officer and director presently has, and in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity. Accordingly, if our officer and director becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We do not believe, however, that the fiduciary duties or contractual obligations of our officer/director will materially affect our ability to complete our business combination.

 

Our executive officer is not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combination targets and monitoring the related due diligence.

 

On December 14, 2021, certain shareholders owning 13,099,243 of our common stock, representing a majority of issued and outstanding shares, agreed to sell their shares to 6 shareholders. This constitutes a change in control of the Company.

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE – 2 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

The accompanying condensed financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying financial statements and notes.

 

lBasis of presentation

 

These accompanying condensed financial statements have been prepared in U.S. Dollars in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the interim period ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis, and the financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 18, 2022.

 

lUse of estimates and assumptions

 

In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.

 

lNet loss per share

 

Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.

 

lIncome taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

 

lUncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.

 

lRelated parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

lCommitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

 

lRecent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.

 

On January 1, 2020, the Company adopted ASU No. 2017-04, “Intangibles and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.22.1
GOING CONCERN UNCERTAINTIES
3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
GOING CONCERN UNCERTAINTIES

NOTE – 3 GOING CONCERN UNCERTAINTIES

 

The accompanying condensed financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However, Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans, which raises substantial doubt about the ability of the Company to continue as a going concern.

 

The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.22.1
AMOUNT DUE TO A RELATED PARTY
3 Months Ended
Mar. 31, 2022
Amount Due To Related Party  
AMOUNT DUE TO A RELATED PARTY

NOTE – 4 AMOUNT DUE TO A RELATED PARTY

 

The amount represented temporary advances from the Company’s director for working capital purpose, which were unsecured, interest-free and had no fixed terms of repayments.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ DEFICIT
3 Months Ended
Mar. 31, 2022
Equity [Abstract]  
STOCKHOLDERS’ DEFICIT

NOTE – 5 STOCKHOLDERS’ DEFICIT

 

Preferred stock

 

The Company’s authorized shares were 300,000,000 shares of preferred stock, with a par value of $0.001.

 

Common Stock

 

The Company’s Articles of Incorporation authorize the issuance of up to 300,000,000 shares of its common stock, par value $0.001 per share, and 10,000,000 preferred shares, also $0.001 par value.

 

There were 14,706,513 and 14,706,513 shares of common stock outstanding at March 31, 2022 and December 31, 2021, respectively.

 

There were no preferred shares issued and outstanding during any periods presented.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAX
3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAX

NOTE – 6 INCOME TAX

 

On December 22, 2017, the 2019 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. The Company does not have any foreign earnings and therefore, we do not anticipate the impact of a transition tax.

 

The cumulative tax effect at the expected rate of 21% as of March 31, 2022 and December 31, 2021 of significant items comprising our net deferred tax amount is as follows:

 

   March 31, 2022   December 31, 2021 
         
Net operating loss carryover  $49,485,838   $49,451,088 
Deferred tax asset   10,392,026    10,384,728 
Impact of rate changes          
Less: valuation allowance   (10,392,026)   (10,384,728)
Net deferred tax asset  $   $ 

 

At March 31, 2022, the Company had net operating loss carry forwards of approximately $49,485,838 that may be offset against future taxable income. The Tax Act also changed the rules on net operating loss carry forwards. The 20-year limitation was eliminated, giving the taxpayer the ability to carry forward losses indefinitely. However, NOL carry forward arising after January 1, 2020, will now be limited to 80 percent of taxable income.

 

No tax benefit has been reported in the period ended March 31, 2022, the Company’s financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for federal income tax reporting purposes are subject to annual limitations. A change in ownership may limit net operating loss carry forwards in future years. The benefits of our deferred tax assets, including our NOLs, built-in losses and tax credits would be reduced or potentially eliminated if we experienced an “ownership change” under Section 382.

 

Based on our analysis performed as of March 31, 2022, the Company has experienced an ownership change as defined by Section 382, and, therefore, the NOLs, built-in losses and tax credits we have generated should be subject to a Section 382 limitation as of this reporting date.

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.22.1
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 31, 2022
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE – 7 RELATED PARTY TRANSACTIONS

 

During the three months ended March 31, 2022 and 2021, the Company has been provided with free office space by its shareholders. The management determined that such cost is nominal and did not recognize the rent expense in its financial statements.

 

Apart from the transactions and balances detailed elsewhere in these accompanying financial statements, the Company has no other significant or material related party transactions during the periods presented.

 

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.22.1
COMMITMENTS AND CONTINGENCIES
3 Months Ended
Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE – 8 COMMITMENTS AND CONTINGENCIES

 

As of March 31, 2022, the Company has no material commitments or contingencies.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.22.1
SUBSEQUENT EVENTS
3 Months Ended
Mar. 31, 2022
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE – 9 SUBSEQUENT EVENTS

 

In accordance with ASC Topic 855, “Subsequent Events”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before condensed financial statements are issued, the Company has evaluated all events or transactions that occurred after March 31, 2022, up through the date the Company issued the unaudited condensed financial statements.

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.22.1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 31, 2022
Accounting Policies [Abstract]  
Basis of presentation

 

lBasis of presentation

 

These accompanying condensed financial statements have been prepared in U.S. Dollars in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the interim period ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis, and the financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 18, 2022.

Use of estimates and assumptions

 

lUse of estimates and assumptions

 

In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.

Net loss per share

 

lNet loss per share

 

Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.

Income taxes

 

lIncome taxes

 

The Company adopted the ASC 740 Income tax provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.

 

The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.

Uncertain tax positions

 

lUncertain tax positions

 

The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.

Related parties

 

lRelated parties

 

The Company follows the ASC 850-10, Related Party for the identification of related parties and disclosure of related party transactions.

 

Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

Commitments and contingencies

 

lCommitments and contingencies

 

The Company follows the ASC 450-20, Commitments to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.

 

If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.

 

Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.

Recent accounting pronouncements

 

lRecent accounting pronouncements

 

From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.

In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “Financial Instruments – Credit Losses (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.

 

On January 1, 2020, the Company adopted ASU No. 2017-04, “Intangibles and Other (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.

 

The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAX (Tables)
3 Months Ended
Mar. 31, 2022
Income Tax Disclosure [Abstract]  
INCOME TAX - Schedule of Deferred Taxes
   March 31, 2022   December 31, 2021 
         
Net operating loss carryover  $49,485,838   $49,451,088 
Deferred tax asset   10,392,026    10,384,728 
Impact of rate changes          
Less: valuation allowance   (10,392,026)   (10,384,728)
Net deferred tax asset  $   $ 
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.22.1
STOCKHOLDERS’ DEFICIT (Details Narrative) - $ / shares
Mar. 31, 2022
Dec. 31, 2021
Equity [Abstract]    
Common Stock, Shares Authorized 300,000,000 300,000,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Preferred Stock, Shares Authorized 10,000,000 10,000,000
Preferred Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock, Shares, Outstanding 14,706,513 14,706,513
Preferred Stock, Shares Issued 0 0
Preferred Stock, Shares Outstanding 0 0
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAX - Schedule of Deferred Taxes (Details) - USD ($)
Mar. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Net operating loss carryover $ 49,485,838 $ 49,451,088
Deferred tax asset 10,392,026 10,384,728
Impact of rate changes    
Less: valuation allowance (10,392,026) (10,384,728)
Net deferred tax asset $ 0 $ 0
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.22.1
INCOME TAX (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2022
Dec. 31, 2021
Income Tax Disclosure [Abstract]    
Effective Income Tax Rate Reconciliation, Percent 21.00% 21.00%
Operating Loss Carryforwards $ 49,485,838  
XML 31 namliong_i10q-033122_htm.xml IDEA: XBRL DOCUMENT 0001342219 2022-01-01 2022-03-31 0001342219 2022-05-10 0001342219 2022-03-31 0001342219 2021-12-31 0001342219 2021-01-01 2021-03-31 0001342219 us-gaap:CommonStockMember 2020-12-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001342219 us-gaap:RetainedEarningsMember 2020-12-31 0001342219 2020-12-31 0001342219 us-gaap:CommonStockMember 2021-12-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001342219 us-gaap:RetainedEarningsMember 2021-12-31 0001342219 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001342219 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001342219 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001342219 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001342219 us-gaap:CommonStockMember 2021-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001342219 us-gaap:RetainedEarningsMember 2021-03-31 0001342219 2021-03-31 0001342219 us-gaap:CommonStockMember 2022-03-31 0001342219 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001342219 us-gaap:RetainedEarningsMember 2022-03-31 0001342219 2021-01-01 2021-12-31 iso4217:USD shares iso4217:USD shares pure 0001342219 false 2022 Q1 --12-31 Yes Yes 10-Q true 2022-03-31 false 000-55909 NAMLIONG SKYCOSMOS, INC. NV 20-3240178 No. 357 Ren’ai Street Yongkang District Tainan City TW 71072 886 2542372 Kreido Biofuels, Inc. Non-accelerated Filer true false true 14706513 0 0 7000 755 28505 0 35505 755 35505 755 10000000 10000000 0.001 0.001 0 0 0 0 0 0 300000000 300000000 0.001 0.001 14706513 14706513 14706513 14706513 14706 14706 49435627 49435627 -49485838 -49451088 -35505 -755 0 0 0 0 34750 2300 34750 2300 -34750 -2300 0 0 -34750 -2300 -0.00 -0.00 -0.00 -0.00 14706513 1956452 14706513 1956452 1956452 1956 48984877 -49057571 -69438 -2300 -2300 1956452 1956 48984877 -49059871 -71738 14706513 14706 49435627 -49451088 -755 -34750 -34750 14706513 14706 49435627 -49485838 -35505 -34750 -2300 6245 975 0 1325 -28505 0 28505 0 28505 0 0 0 0 0 0 0 0 0 <p id="xdx_802_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zPtztX9rKTuf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 1 <span id="xdx_824_zmE0HEJ0x57g">DESCRIPTION OF BUSINESS AND ORGANIZATION</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Namliong Skycosmos, Inc. (formerly Kreido Biofuels, Inc.) (the “Company” or “KRBF”) was incorporated as Gemwood Productions, Inc. under the laws of the State of Nevada on February 7, 2005. Gemwood Productions, Inc. changed its name to Kreido Biofuels, Inc. on November 2, 2006. On April 19, 2022, we changed the company name to Namliong Skycosmos, Inc.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our current business will be to seek to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, initiated any substantive discussions, directly or indirectly, with any business combination target.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our acquisition strategy will be to assess a broad range of potential business combination targets and complete a business combination.   In doing so, we will evaluate the historical financial statements of the target, its management, and projected future results. In evaluating a prospective target business, we expect to conduct a thorough due diligence review that will encompass, among other things, meetings with incumbent management and employees, document reviews, inspection of facilities, as well as a review of financial and other information that will be made available to us.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We are not prohibited from pursuing a business combination with a company that is affiliated with our management, but we have no plans to do so. We do not plan to retain a significant equity position after closing of any acquisition and management does not plan to continue as part of the new management team.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We have not selected any specific business combination target. Our sole officer and director presently has, and in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity. Accordingly, if our officer and director becomes aware of a business combination opportunity which is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she will honor his or her fiduciary or contractual obligations to present such opportunity to such entity. We do not believe, however, that the fiduciary duties or contractual obligations of our officer/director will materially affect our ability to complete our business combination.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Our executive officer is not required to commit any specified amount of time to our affairs, and, accordingly, will have conflicts of interest in allocating management time among various business activities, including identifying potential business combination targets and monitoring the related due diligence.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 14, 2021, certain shareholders owning 13,099,243 of our common stock, representing a majority of issued and outstanding shares, agreed to sell their shares to 6 shareholders. This constitutes a change in control of the Company.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_801_eus-gaap--SignificantAccountingPoliciesTextBlock_zHq3PBxGoxXc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 2 <span id="xdx_821_zg8ejfC9gPg5">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed financial statements reflect the application of certain significant accounting policies as described in this note and elsewhere in the accompanying financial statements and notes.</p> <p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zvLzviLGjK6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_863_zBLM8SUD3BWl">Basis of presentation</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These accompanying condensed financial statements have been prepared in U.S. Dollars in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the interim period ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis, and the financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 18, 2022.</p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zbGKZS1ZqrF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_868_zWdPS2JU45oa">Use of estimates and assumptions</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zACjq5NckLEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_86E_zxME3aKgUoKc">Net loss per share</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.</p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zcHHEtYV6DFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_86D_zs9AOKMOdqVb">Income taxes</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted the ASC 740 <i>Income tax</i> provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.</p> <p id="xdx_84C_eus-gaap--IncomeTaxUncertaintiesPolicy_zH2fU79V1PK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_862_ztZc43KQjZmd">Uncertain tax positions</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_848_ecustom--RelatedPartiesPolicyTextBlock_zRvKFRM3t7h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_862_zgp6qbdTlj46">Related parties</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the ASC 850-10, <i>Related Party</i> for the identification of related parties and disclosure of related party transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</p> <p id="xdx_849_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zy9ow0u8fqL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_86C_ztrDBZ3o56T8">Commitments and contingencies</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the ASC 450-20, <i>Commitments</i> to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zMSDO4n0GgP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_866_zCBPetq4iSu6">Recent accounting pronouncements</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “<i>Financial Instruments – Credit Losses</i> (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 1, 2020, the Company adopted ASU No. 2017-04, “<i>Intangibles and Other</i> (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_84F_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zvLzviLGjK6e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_863_zBLM8SUD3BWl">Basis of presentation</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">These accompanying condensed financial statements have been prepared in U.S. Dollars in conformity with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to make the financial statements not misleading have been included. Operating results for the interim period ended March 31, 2022 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2022. The information included in this Form 10-Q should be read in conjunction with Management’s Discussion and Analysis, and the financial statements and notes thereto included in the Company’s Form 10-K for the fiscal year ended December 31, 2021, filed with the SEC on March 18, 2022.</p> <p id="xdx_84B_eus-gaap--UseOfEstimates_zbGKZS1ZqrF7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_868_zWdPS2JU45oa">Use of estimates and assumptions</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In preparing these condensed financial statements, management makes estimates and assumptions that affect the reported amounts of assets and liabilities in the balance sheet and revenues and expenses during the periods reported. Actual results may differ from these estimates.</p> <p id="xdx_84D_eus-gaap--EarningsPerSharePolicyTextBlock_zACjq5NckLEd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_86E_zxME3aKgUoKc">Net loss per share</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Basic loss per share is calculated by dividing the Company’s net loss applicable to common shareholders by the weighted average number of common shares during the period. Diluted earnings per share is calculated by dividing the Company’s net income available to common shareholders by the diluted weighted average number of shares outstanding during the period.</p> <p id="xdx_846_eus-gaap--IncomeTaxPolicyTextBlock_zcHHEtYV6DFb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_86D_zs9AOKMOdqVb">Income taxes</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company adopted the ASC 740 <i>Income tax</i> provisions of paragraph 740-10-25-13, which addresses the determination of whether tax benefits claimed or expected to be claimed on a tax return should be recorded in the condensed financial statements. Under paragraph 740-10-25-13, the Company may recognize the tax benefit from an uncertain tax position only if it is more likely than not that the tax position will be sustained on examination by the taxing authorities, based on the technical merits of the position. The tax benefits recognized in the condensed financial statements from such a position should be measured based on the largest benefit that has a greater than fifty percent (50%) likelihood of being realized upon ultimate settlement. Paragraph 740-10-25-13 also provides guidance on de-recognition, classification, interest and penalties on income taxes, accounting in interim periods and requires increased disclosures. The Company had no material adjustments to its liabilities for unrecognized income tax benefits according to the provisions of paragraph 740-10-25-13.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The estimated future tax effects of temporary differences between the tax basis of assets and liabilities are reported in the accompanying balance sheets, as well as tax credit carry-backs and carry-forwards. The Company periodically reviews the recoverability of deferred tax assets recorded on its balance sheets and provides valuation allowances as management deems necessary.</p> <p id="xdx_84C_eus-gaap--IncomeTaxUncertaintiesPolicy_zH2fU79V1PK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_862_ztZc43KQjZmd">Uncertain tax positions</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company did not take any uncertain tax positions and had no adjustments to its income tax liabilities or benefits pursuant to the ASC 740 provisions of Section 740-10-25 for the periods ended March 31, 2022 and 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p id="xdx_848_ecustom--RelatedPartiesPolicyTextBlock_zRvKFRM3t7h6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_862_zgp6qbdTlj46">Related parties</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the ASC 850-10, <i>Related Party</i> for the identification of related parties and disclosure of related party transactions.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Pursuant to section 850-10-20 the related parties include a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and Income-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The condensed financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a) the nature of the relationship(s) involved; b) a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c) the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d) amount due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.</p> <p id="xdx_849_eus-gaap--CommitmentsAndContingenciesPolicyTextBlock_zy9ow0u8fqL6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_86C_ztrDBZ3o56T8">Commitments and contingencies</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company follows the ASC 450-20, <i>Commitments</i> to report accounting for contingencies. Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but which will only be resolved when one or more future events occur or fail to occur. The Company assesses such contingent liabilities, and such assessment inherently involves an exercise of judgment. In assessing loss contingencies related to legal proceedings that are pending against the Company or un-asserted claims that may result in such proceedings, the Company evaluates the perceived merits of any legal proceedings or un-asserted claims as well as the perceived merits of the amount of relief sought or expected to be sought therein.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company’s condensed financial statements. If the assessment indicates that a potentially material loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, then the nature of the contingent liability, and an estimate of the range of possible losses, if determinable and material, would be disclosed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Loss contingencies considered remote are generally not disclosed unless they involve guarantees, in which case the guarantees would be disclosed. Management does not believe, based upon information available at this time that these matters will have a material adverse effect on the Company’s financial position, results of operations or cash flows. However, there is no assurance that such matters will not materially and adversely affect the Company’s business, financial position, and results of operations or cash flows.</p> <p id="xdx_84A_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zMSDO4n0GgP" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top"> <td style="width: 0"/><td style="width: 29.4pt"><span style="font-family: Wingdings">l</span></td><td style="text-align: justify"><span id="xdx_866_zCBPetq4iSu6">Recent accounting pronouncements</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">From time to time, new accounting pronouncements are issued by the Financial Accounting Standard Board (“FASB”) or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its financial position or results of operations upon adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In September 2016, the Financial Accounting Standards Board (“FASB”) issued ASU No. 2016-13, “<i>Financial Instruments – Credit Losses</i> (Topic 326)” (“ASU 2016-13”), which requires the immediate recognition of management’s estimates of current and expected credit losses. In November 2018, the FASB issued ASU 2018-19, which makes certain improvements to Topic 326. In April and May 2019, the FASB issued ASUs 2019-04 and 2019-05, respectively, which adds codification improvements and transition relief for Topic 326. In November 2019, the FASB issued ASU 2019-10, which delays the effective date of Topic 326 for Smaller Reporting Companies to interim and annual periods beginning after December 15, 2022, with early adoption permitted. In November 2019, the FASB issued ASU 2019-11, which makes improvements to certain areas of Topic 326. In February 2020, the FASB issued ASU 2020-02, which adds an SEC paragraph, pursuant to the issuance of SEC Staff Accounting Bulletin No. 119, to Topic 326. Topic 326 is effective for the Company for fiscal years and interim reporting periods within those years beginning after December 15, 2022. Early adoption is permitted for interim and annual periods beginning December 15, 2019. The Company is currently evaluating the potential impact of adopting this guidance on the financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On January 1, 2020, the Company adopted ASU No. 2017-04, “<i>Intangibles and Other</i> (Topic 350): Simplifying the Test for Goodwill Impairment”, which eliminates the requirement to calculate the implied fair value of goodwill, but rather requires an entity to record an impairment charge based on the excess of a reporting unit’s carrying value over its fair value. Adoption of this ASU did not have a material effect on the condensed financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company has reviewed all recently issued, but not yet effective, accounting pronouncements and does not believe the future adoption of any such pronouncements may be expected to cause a material impact on its financial condition or the results of its operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_80C_eus-gaap--SubstantialDoubtAboutGoingConcernTextBlock_zTrdtM8L76vk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 3 <span id="xdx_826_zojPjaeltHTb">GOING CONCERN UNCERTAINTIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The accompanying condensed financial statements have been prepared using the going concern basis of accounting, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In order to continue as a going concern, the Company will need, among other things, additional capital resources. Management's plan is to obtain such resources for the Company by obtaining capital from management sufficient to meet its minimal operating expenses and seeking equity and/or debt financing. However, Management cannot provide any assurances that the Company will be successful in accomplishing any of its plans, which raises substantial doubt about the ability of the Company to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_801_ecustom--RelatedPartyTransactionsDisclosure1TextBlock_z3E2MKBZ6PWf" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 4 <span id="xdx_822_zeAXUW0nwFi2">AMOUNT DUE TO A RELATED PARTY</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 25.7pt; text-align: justify; text-indent: -25.7pt"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The amount represented temporary advances from the Company’s director for working capital purpose, which were unsecured, interest-free and had no fixed terms of repayments.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 25.7pt; text-align: justify; text-indent: -25.7pt"> </p> <p id="xdx_805_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zlUnDcyDJ7jl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 5 <span id="xdx_823_z7wvKWWL1N76">STOCKHOLDERS’ DEFICIT</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Preferred stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s authorized shares were <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_iI_c20220331_zFYqtNoupeqb" title="Common Stock, Shares Authorized">300,000,000</span> shares of preferred stock, with a par value of $<span id="xdx_90C_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zIUJjmbXa54a" title="Common Stock, Par or Stated Value Per Share">0.001</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Common Stock</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company’s Articles of Incorporation authorize the issuance of up to <span id="xdx_909_eus-gaap--CommonStockSharesAuthorized_c20220331_pdd" title="Common Stock, Shares Authorized">300,000,000</span> shares of its common stock, par value $<span id="xdx_90B_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20220331_zFjJk37Ulzka">0.001</span> per share, and <span id="xdx_905_eus-gaap--PreferredStockSharesAuthorized_iI_c20220331_zK4mMZ079MV3">10,000,000</span> preferred shares, also $<span id="xdx_901_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20220331_zE21DGCERXdf">0.001</span> par value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were <span id="xdx_906_eus-gaap--CommonStockSharesOutstanding_iI_c20220331_z3AtYJR8Wrta">14,706,513</span> and <span id="xdx_904_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zJelEGC4ivQh">14,706,513</span> shares of common stock outstanding at March 31, 2022 and December 31, 2021, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">There were <span id="xdx_905_eus-gaap--PreferredStockSharesIssued_iI_do_c20220331_zYUAilXNZjqd"><span id="xdx_906_eus-gaap--PreferredStockSharesOutstanding_iI_do_c20220331_z6gPFB0lxord">no</span></span> preferred shares issued and outstanding during any periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"/> 300000000 0.001 300000000 0.001 10000000 0.001 14706513 14706513 0 0 <p id="xdx_80C_eus-gaap--IncomeTaxDisclosureTextBlock_zYuMNna8rbad" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 6 <span id="xdx_823_zcGczFKFSeUa">INCOME TAX</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">On December 22, 2017, the 2019 Tax Cuts and Jobs Act (the “Tax Act”) was enacted into law including a one-time mandatory transition tax on accumulated foreign earnings and a reduction of the corporate income tax rate to 21% effective January 1, 2018, among others. We are required to recognize the effect of the tax law changes in the period of enactment, such as determining the transition tax, remeasuring our U.S. deferred tax assets and liabilities as well as reassessing the net realizability of our deferred tax assets and liabilities. The Company does not have any foreign earnings and therefore, we do not anticipate the impact of a transition tax.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The cumulative tax effect at the expected rate of <span id="xdx_902_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20220101__20220331_z4PYwI9ytWAb"><span id="xdx_90E_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_dp_c20210101__20211231_z1UajYCJseIc">21</span></span>% as of March 31, 2022 and December 31, 2021 of significant items comprising our net deferred tax amount is as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zyeQA5AYVkNi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX - Schedule of Deferred Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20220331_zWpNAwkU9Kdg" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20211231_z1GwADaTIjT2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zq17deqHs2T1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Net operating loss carryover</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">49,485,838</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">49,451,088</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGross_iI_zYKxmqA4azcc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred tax asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,392,026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,384,728</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ImpactOfRateChangesAbstract_iB_zRjmHJ3qo0Se" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Impact of rate changes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z9A9UHNHOLw2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,392,026</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,384,728</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsNet_iI_d0_zKPubtMW3nz4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">At March 31, 2022, the Company had net operating loss carry forwards of approximately $<span id="xdx_903_eus-gaap--OperatingLossCarryforwards_iI_pp0p0_c20220331_zb4ZutqS7lhf" title="Operating Loss Carryforwards">49,485,838</span> that may be offset against future taxable income. The Tax Act also changed the rules on net operating loss carry forwards. The 20-year limitation was eliminated, giving the taxpayer the ability to carry forward losses indefinitely. However, NOL carry forward arising after January 1, 2020, will now be limited to 80 percent of taxable income.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">No tax benefit has been reported in the period ended March 31, 2022, the Company’s financial statements since the potential tax benefit is offset by a valuation allowance of the same amount. Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for federal income tax reporting purposes are subject to annual limitations. A change in ownership may limit net operating loss carry forwards in future years. The benefits of our deferred tax assets, including our NOLs, built-in losses and tax credits would be reduced or potentially eliminated if we experienced an “ownership change” under Section 382.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Based on our analysis performed as of March 31, 2022, the Company has experienced an ownership change as defined by Section 382, and, therefore, the NOLs, built-in losses and tax credits we have generated should be subject to a Section 382 limitation as of this reporting date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> 0.21 0.21 <table cellpadding="0" cellspacing="0" id="xdx_88D_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zyeQA5AYVkNi" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - INCOME TAX - Schedule of Deferred Taxes (Details)"> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_495_20220331_zWpNAwkU9Kdg" style="border-bottom: Black 1pt solid; text-align: center">March 31, 2022</td><td style="padding-bottom: 1pt"> </td><td style="padding-bottom: 1pt"> </td> <td colspan="2" id="xdx_490_20211231_z1GwADaTIjT2" style="border-bottom: Black 1pt solid; text-align: center">December 31, 2021</td><td style="padding-bottom: 1pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: justify"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_zq17deqHs2T1" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="width: 66%; text-align: justify">Net operating loss carryover</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">49,485,838</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">49,451,088</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DeferredTaxAssetsGross_iI_zYKxmqA4azcc" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Deferred tax asset</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,392,026</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,384,728</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--ImpactOfRateChangesAbstract_iB_zRjmHJ3qo0Se" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left">Impact of rate changes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_di_z9A9UHNHOLw2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1pt">Less: valuation allowance</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,392,026</td><td style="padding-bottom: 1pt; text-align: left">)</td><td style="padding-bottom: 1pt"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right">(10,384,728</td><td style="padding-bottom: 1pt; text-align: left">)</td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsNet_iI_d0_zKPubtMW3nz4" style="vertical-align: bottom; background-color: rgb(238,238,238)"> <td style="text-align: left; padding-bottom: 2.5pt">Net deferred tax asset</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">–</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 49485838 49451088 10392026 10384728 10392026 10384728 0 0 49485838 <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zETxNDi1Ndjl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 7 <span id="xdx_827_zS17iOih3B83">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">During the three months ended March 31, 2022 and 2021, the Company has been provided with free office space by its shareholders. The management determined that such cost is nominal and did not recognize the rent expense in its financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Apart from the transactions and balances detailed elsewhere in these accompanying financial statements, the Company has no other significant or material related party transactions during the periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_802_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zwkJuGddozXg" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 8 <span id="xdx_82B_zracyC2L2Lti">COMMITMENTS AND CONTINGENCIES</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">As of March 31, 2022, the Company has no material commitments or contingencies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p id="xdx_80E_eus-gaap--ScheduleOfSubsequentEventsTextBlock_zqOmFdXzGEI4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>NOTE – 9 <span id="xdx_824_zxbJub5Ka9Vh">SUBSEQUENT EVENTS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In accordance with ASC Topic 855, “<i>Subsequent Events</i>”, which establishes general standards of accounting for and disclosure of events that occur after the balance sheet date but before condensed financial statements are issued, the Company has evaluated all events or transactions that occurred after March 31, 2022, up through the date the Company issued the unaudited condensed financial statements.</p> EXCEL 32 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 34 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 35 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 26 94 1 false 3 0 false 4 false false R1.htm 00000001 - Document - Cover Sheet http://kreidobiofuels.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets (Unaudited) Sheet http://kreidobiofuels.com/role/BalanceSheets Condensed Balance Sheets (Unaudited) Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical) Sheet http://kreidobiofuels.com/role/BalanceSheetsParenthetical Condensed Balance Sheets (Unaudited) (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://kreidobiofuels.com/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit) Sheet http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit Condensed Statements of Changes in Stockholders' Equity (Deficit) Statements 5 false false R6.htm 00000006 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://kreidobiofuels.com/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 00000007 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION Sheet http://kreidobiofuels.com/role/DescriptionOfBusinessAndOrganization DESCRIPTION OF BUSINESS AND ORGANIZATION Notes 7 false false R8.htm 00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 8 false false R9.htm 00000009 - Disclosure - GOING CONCERN UNCERTAINTIES Sheet http://kreidobiofuels.com/role/GoingConcernUncertainties GOING CONCERN UNCERTAINTIES Notes 9 false false R10.htm 00000010 - Disclosure - AMOUNT DUE TO A RELATED PARTY Sheet http://kreidobiofuels.com/role/AmountDueToRelatedParty AMOUNT DUE TO A RELATED PARTY Notes 10 false false R11.htm 00000011 - Disclosure - STOCKHOLDERS??? DEFICIT Sheet http://kreidobiofuels.com/role/StockholdersDeficit STOCKHOLDERS??? DEFICIT Notes 11 false false R12.htm 00000012 - Disclosure - INCOME TAX Sheet http://kreidobiofuels.com/role/IncomeTax INCOME TAX Notes 12 false false R13.htm 00000013 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://kreidobiofuels.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 13 false false R14.htm 00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://kreidobiofuels.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 14 false false R15.htm 00000015 - Disclosure - SUBSEQUENT EVENTS Sheet http://kreidobiofuels.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 15 false false R16.htm 00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 16 false false R17.htm 00000017 - Disclosure - INCOME TAX (Tables) Sheet http://kreidobiofuels.com/role/IncomeTaxTables INCOME TAX (Tables) Tables http://kreidobiofuels.com/role/IncomeTax 17 false false R18.htm 00000018 - Disclosure - STOCKHOLDERS??? DEFICIT (Details Narrative) Sheet http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative STOCKHOLDERS??? DEFICIT (Details Narrative) Details http://kreidobiofuels.com/role/StockholdersDeficit 18 false false R19.htm 00000019 - Disclosure - INCOME TAX - Schedule of Deferred Taxes (Details) Sheet http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails INCOME TAX - Schedule of Deferred Taxes (Details) Details 19 false false R20.htm 00000020 - Disclosure - INCOME TAX (Details Narrative) Sheet http://kreidobiofuels.com/role/IncomeTaxDetailsNarrative INCOME TAX (Details Narrative) Details http://kreidobiofuels.com/role/IncomeTaxTables 20 false false All Reports Book All Reports namliong_i10q-033122.htm krbf-20220331.xsd krbf-20220331_cal.xml krbf-20220331_def.xml krbf-20220331_lab.xml krbf-20220331_pre.xml namliong_ex3101.htm namliong_ex3102.htm namliong_ex3201.htm namliong_ex3202.htm http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 37 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "namliong_i10q-033122.htm": { "axisCustom": 0, "axisStandard": 1, "contextCount": 26, "dts": { "calculationLink": { "local": [ "krbf-20220331_cal.xml" ] }, "definitionLink": { "local": [ "krbf-20220331_def.xml" ] }, "inline": { "local": [ "namliong_i10q-033122.htm" ] }, "labelLink": { "local": [ "krbf-20220331_lab.xml" ] }, "presentationLink": { "local": [ "krbf-20220331_pre.xml" ] }, "schema": { "local": [ "krbf-20220331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 157, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 10, "http://xbrl.sec.gov/dei/2022": 7, "total": 17 }, "keyCustom": 2, "keyStandard": 92, "memberCustom": 0, "memberStandard": 3, "nsprefix": "KRBF", "nsuri": "http://kreidobiofuels.com/20220331", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://kreidobiofuels.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "KRBF:RelatedPartyTransactionsDisclosure1TextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - AMOUNT DUE TO A RELATED PARTY", "role": "http://kreidobiofuels.com/role/AmountDueToRelatedParty", "shortName": "AMOUNT DUE TO A RELATED PARTY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "KRBF:RelatedPartyTransactionsDisclosure1TextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - STOCKHOLDERS\u2019 DEFICIT", "role": "http://kreidobiofuels.com/role/StockholdersDeficit", "shortName": "STOCKHOLDERS\u2019 DEFICIT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - INCOME TAX", "role": "http://kreidobiofuels.com/role/IncomeTax", "shortName": "INCOME TAX", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://kreidobiofuels.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://kreidobiofuels.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - SUBSEQUENT EVENTS", "role": "http://kreidobiofuels.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - INCOME TAX (Tables)", "role": "http://kreidobiofuels.com/role/IncomeTaxTables", "shortName": "INCOME TAX (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - STOCKHOLDERS\u2019 DEFICIT (Details Narrative)", "role": "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 DEFICIT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R19": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - INCOME TAX - Schedule of Deferred Taxes (Details)", "role": "http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails", "shortName": "INCOME TAX - Schedule of Deferred Taxes (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Condensed Balance Sheets (Unaudited)", "role": "http://kreidobiofuels.com/role/BalanceSheets", "shortName": "Condensed Balance Sheets (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - INCOME TAX (Details Narrative)", "role": "http://kreidobiofuels.com/role/IncomeTaxDetailsNarrative", "shortName": "INCOME TAX (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateContinuingOperations", "reportCount": 1, "unique": true, "unitRef": "Percent", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Condensed Balance Sheets (Unaudited) (Parenthetical)", "role": "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Unaudited) (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2022-03-31", "decimals": "INF", "lang": null, "name": "us-gaap:CommonStockSharesIssued", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Condensed Statements of Operations (Unaudited)", "role": "http://kreidobiofuels.com/role/StatementsOfOperations", "shortName": "Condensed Statements of Operations (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Condensed Statements of Changes in Stockholders' Equity (Deficit)", "role": "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit", "shortName": "Condensed Statements of Changes in Stockholders' Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "AsOf2020-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Condensed Statements of Cash Flows (Unaudited)", "role": "http://kreidobiofuels.com/role/StatementsOfCashFlows", "shortName": "Condensed Statements of Cash Flows (Unaudited)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - DESCRIPTION OF BUSINESS AND ORGANIZATION", "role": "http://kreidobiofuels.com/role/DescriptionOfBusinessAndOrganization", "shortName": "DESCRIPTION OF BUSINESS AND ORGANIZATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPolicies", "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - GOING CONCERN UNCERTAINTIES", "role": "http://kreidobiofuels.com/role/GoingConcernUncertainties", "shortName": "GOING CONCERN UNCERTAINTIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "namliong_i10q-033122.htm", "contextRef": "From2022-01-01to2022-03-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubstantialDoubtAboutGoingConcernTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 3, "tag": { "KRBF_DisclosureAmountDueToRelatedPartyAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Amount Due To Related Party" } } }, "localname": "DisclosureAmountDueToRelatedPartyAbstract", "nsuri": "http://kreidobiofuels.com/20220331", "xbrltype": "stringItemType" }, "KRBF_ImpactOfRateChangesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Impact of rate changes" } } }, "localname": "ImpactOfRateChangesAbstract", "nsuri": "http://kreidobiofuels.com/20220331", "presentation": [ "http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails" ], "xbrltype": "stringItemType" }, "KRBF_RelatedPartiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related parties" } } }, "localname": "RelatedPartiesPolicyTextBlock", "nsuri": "http://kreidobiofuels.com/20220331", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "KRBF_RelatedPartyTransactionsDisclosure1TextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "AMOUNT DUE TO A RELATED PARTY" } } }, "localname": "RelatedPartyTransactionsDisclosure1TextBlock", "nsuri": "http://kreidobiofuels.com/20220331", "presentation": [ "http://kreidobiofuels.com/role/AmountDueToRelatedParty" ], "xbrltype": "textBlockItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r222", "r224", "r225" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r223" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r214" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r217" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r230" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInformationFormerLegalOrRegisteredName": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Former Legal or Registered Name of an entity", "label": "Entity Information, Former Legal or Registered Name" } } }, "localname": "EntityInformationFormerLegalOrRegisteredName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r227" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r225" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r213" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r224" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r218" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r219" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r212" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r215" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r221" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r229" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://kreidobiofuels.com/role/Cover" ], "xbrltype": "booleanItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r15" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r9", "r186" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r47", "r48", "r49", "r133", "r134", "r135", "r167" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r6", "r42", "r82", "r85", "r91", "r97", "r104", "r105", "r106", "r108", "r109", "r110", "r111", "r112", "r113", "r115", "r116", "r161", "r163", "r170", "r184", "r186", "r189", "r195" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current asset:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_Cash": { "auth_ref": [ "r5", "r186", "r207", "r208" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r32", "r37", "r39" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "END OF PERIOD", "periodStartLabel": "BEGINNING OF PERIOD" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r32", "r171" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Net change in cash and cash equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r18", "r191", "r198" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r99", "r100", "r101", "r102", "r209" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": { "auth_ref": [ "r103", "r210" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.", "label": "Commitments and Contingencies, Policy [Policy Text Block]", "verboseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingenciesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r47", "r48", "r167" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r8", "r130" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r8", "r186" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common stock, 300,000,000 shares authorized, $0.001 par value, 14,706,513 and 14,706,513 shares issued and outstanding as of March 31, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r143" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred tax asset" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r145" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Net deferred tax asset" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r149", "r150" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryover" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r144" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Less: valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTax-ScheduleOfDeferredTaxesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r14", "r45", "r107", "r109", "r110", "r114", "r115", "r116", "r181" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Amount due to a related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r28", "r52", "r53", "r54", "r55", "r56", "r60", "r62", "r64", "r65", "r66", "r69", "r70", "r168", "r169", "r193", "r200" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net loss per share \u2013 Basic and Diluted" } } }, "localname": "EarningsPerShareBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r28", "r52", "r53", "r54", "r55", "r56", "r62", "r64", "r65", "r66", "r69", "r70", "r168", "r169", "r193", "r200" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r67", "r68" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Net loss per share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r139" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r23", "r24", "r25", "r47", "r48", "r49", "r51", "r57", "r59", "r71", "r98", "r130", "r131", "r133", "r134", "r135", "r152", "r153", "r167", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r29" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r43", "r140", "r141", "r147", "r154", "r156", "r158", "r159", "r160" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAX" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTax" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r44", "r58", "r59", "r81", "r138", "r155", "r157", "r201" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income tax expense" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r22", "r136", "r137", "r141", "r142", "r146", "r151" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxUncertaintiesPolicy": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for tax positions taken in the tax return filed or to be filed for which it is more likely than not that the tax position will not be sustained upon examination by taxing authorities and other types of contingencies related to income taxes.", "label": "Uncertain tax positions" } } }, "localname": "IncomeTaxUncertaintiesPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r35" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableRelatedParties": { "auth_ref": [ "r35" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the obligations due for goods and services provided by the following types of related parties: a parent company and its subsidiaries, subsidiaries of a common parent, an entity and trust for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of the entities' management, an entity and its principal owners, management, or member of their immediate families, affiliates, or other parties with the ability to exert significant influence.", "label": "Accounts payable, related party" } } }, "localname": "IncreaseDecreaseInAccountsPayableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Change in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r31", "r33", "r38" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r16", "r42", "r86", "r97", "r104", "r105", "r106", "r109", "r110", "r111", "r112", "r113", "r115", "r116", "r162", "r163", "r164", "r170", "r184", "r185" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "TOTAL LIABILITIES" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r13", "r42", "r97", "r170", "r186", "r190", "r197" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "TOTAL LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LIABILITIES AND STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r4", "r17", "r42", "r97", "r104", "r105", "r106", "r109", "r110", "r111", "r112", "r113", "r115", "r116", "r162", "r163", "r164", "r170", "r184", "r185", "r186" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r32" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r32", "r34", "r36" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r20", "r21", "r25", "r27", "r36", "r42", "r50", "r52", "r53", "r54", "r55", "r58", "r59", "r63", "r82", "r84", "r87", "r90", "r92", "r97", "r104", "r105", "r106", "r109", "r110", "r111", "r112", "r113", "r115", "r116", "r169", "r170", "r192", "r199" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://kreidobiofuels.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss for the period", "totalLabel": "NET LOSS", "verboseLabel": "Net loss" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows", "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit", "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recent accounting pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://kreidobiofuels.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total operating expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r82", "r84", "r87", "r90", "r92" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "LOSS FROM OPERATION" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r148" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTaxDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r3", "r165" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "DESCRIPTION OF BUSINESS AND ORGANIZATION" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/DescriptionOfBusinessAndOrganization" ], "xbrltype": "textBlockItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r7", "r117" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r7", "r117" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheetsParenthetical", "http://kreidobiofuels.com/role/StockholdersDeficitDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r7", "r186" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred stock, 10,000,000 shares authorized, $0.001 par value, 0 shares issued and outstanding as of March 31, 2022 and December 31, 2021" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r30" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Advance from a related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r179", "r180", "r181", "r182", "r183" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r10", "r131", "r186", "r196", "r205", "r206" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r47", "r48", "r49", "r51", "r57", "r59", "r98", "r133", "r134", "r135", "r152", "r153", "r167", "r202", "r204" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r26", "r42", "r79", "r80", "r83", "r88", "r89", "r93", "r94", "r95", "r97", "r104", "r105", "r106", "r109", "r110", "r111", "r112", "r113", "r115", "r116", "r170", "r194" ], "calculation": { "http://kreidobiofuels.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenue, net" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "INCOME TAX - Schedule of Deferred Taxes" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/IncomeTaxTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfSubsequentEventsTextBlock": { "auth_ref": [ "r187" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, losses resulting from fire or flood, losses on receivables, significant realized and unrealized gains and losses that result from changes in quoted market prices of securities, declines in market prices of inventory, changes in authorized or issued debt (SEC), significant foreign exchange rate changes, substantial loans to insiders or affiliates, significant long-term investments, and substantial dividends not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "ScheduleOfSubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Shares, Outstanding, Ending Balance", "periodStartLabel": "Shares, Outstanding, Beginning Balance" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r40", "r46" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r19", "r23", "r24", "r25", "r47", "r48", "r49", "r51", "r57", "r59", "r71", "r98", "r130", "r131", "r133", "r134", "r135", "r152", "r153", "r167", "r172", "r173", "r174", "r175", "r176", "r177", "r178", "r202", "r203", "r204" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r47", "r48", "r49", "r71", "r188" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r8", "r11", "r12", "r42", "r96", "r97", "r170", "r186" ], "calculation": { "http://kreidobiofuels.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders\u2019 deficit", "periodEndLabel": "Ending balance, value", "periodStartLabel": "Beginning balance, value" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets", "http://kreidobiofuels.com/role/StatementsOfChangesInStockholdersEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r41", "r118", "r119", "r120", "r121", "r122", "r123", "r124", "r125", "r126", "r127", "r128", "r129", "r131", "r132", "r166" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "verboseLabel": "STOCKHOLDERS\u2019 DEFICIT" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StockholdersDeficit" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubstantialDoubtAboutGoingConcernTextBlock": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure when substantial doubt is raised about the ability to continue as a going concern. Includes, but is not limited to, principal conditions or events that raised substantial doubt about the ability to continue as a going concern, management's evaluation of the significance of those conditions or events in relation to the ability to meet its obligations, and management's plans that alleviated or are intended to mitigate the conditions or events that raise substantial doubt about the ability to continue as a going concern.", "label": "GOING CONCERN UNCERTAINTIES" } } }, "localname": "SubstantialDoubtAboutGoingConcernTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/GoingConcernUncertainties" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r72", "r73", "r74", "r75", "r76", "r77", "r78" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of estimates and assumptions" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/SummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r61", "r66" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "verboseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r60", "r66" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "verboseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasicAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted average common shares outstanding" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasicAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://kreidobiofuels.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" } }, "unitCount": 4 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r101": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r102": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "460", "URI": "https://asc.fasb.org/extlink&oid=126907703&loc=d3e12565-110249" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r132": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r165": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r183": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r2": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "40", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=51888271" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "450", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491354&loc=d3e6049-115624" }, "r211": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r212": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r213": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r214": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r215": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r216": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r217": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r218": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r219": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r220": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r221": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r222": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r223": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r224": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r225": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r226": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r227": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r228": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r229": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r230": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r3": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r46": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" } }, "version": "2.1" } ZIP 38 0001683168-22-003411-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001683168-22-003411-xbrl.zip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